Efficacy of Empagliflozin on Liver Enzymes, Lipid Profile and BMI in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD): A Systematic Review and Meta‐Analysis (Endocrinology, Diabetes & Metabolism, 2026)